Global Compounding Pharmacy Market

Compounding Pharmacy Comprehensive Study by Type (Oral (Capsules, Tablets, suspensions, lozenges, lollipops), Topical (Cream, gel, ointments, lotions), Mouthwashes, Suppositories, Injectables (Injections, infusions, concentrates, reconstitution, gels), Ophthalmic, By end users (Adult ,Pediatric, Geriatric,Veterinary)), Application (Pain management, Therapeutic interventions, Hormone replacement therapy), Therapeutic area (Pain Management, Dermatology, Hormone replacement, Specialty drugs, Nutritional Supplements, Others), Sterility (Sterile, Non Sterile), End user (Adult, Pediatric, Geriatric, Veterinary), Distribution channel (Hospital Pharmacy, Consulting pharmacy) Players and Region - Global Market Outlook to 2026

Compounding Pharmacy Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Compounding Pharmacy Market Scope
With the increase in the number of dispensed prescriptions, Rising geriatric population coupled with favorable demographic trends such as improved life expectancy are driving the global market of compounding pharmacy. People around the world suffering from diseases there is a need for specialized formulations like compounding pharmacy. Compounding pharmacy deals with the introduction of new formulations effective in treating various diseases. The compounding pharmacy is the process of mixing, combining, or alteration of the ingredients to produce personalized medication for individual patients to treat various diseases. It is customized dosage forms and/or prescription medications to meet an individual patient’s needs. They are supplying such drugs for patients who do not improve by consuming commercially available drugs.

According to AMA, the Global Compounding Pharmacy market is expected to see growth rate of 7.6%

The market is fragmented by a large number of vendors who are involved in adopting the various strategies for compounding pharmacy market and to sustain in the competitive environment.The Players having a strong hold in the market are Fagron. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Compounding Pharmacy market throughout the predicted period.

AmerisourceBergen (United States), Rx3 Pharmacy (United States), Agbi’s Sterile Compounding Pharmacy LLC (U.K), B. Braun Medical Inc. (Germany), Cantrell Drug Company, Inc. (United States), Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India), Village Sterile Compounding Pharmacy (United States), Imprimis Pharmaceuticals, Inc. (United States), Institutional Pharmacies Of Louisiana LLC (United States), Lorraine's Pharmacy (Canada), McGuff Sterile Compounding Pharmacy Services, Inc. (United States) and Panaceutics Inc., Pencol Compounding Pharmacy (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Fagron (Netherlands) and ITC Compounding Pharmacy (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Compounding Pharmacy market by Type (Oral (Capsules, Tablets, suspensions, lozenges, lollipops), Topical (Cream, gel, ointments, lotions), Mouthwashes, Suppositories, Injectables (Injections, infusions, concentrates, reconstitution, gels), Ophthalmic and By end users (Adult ,Pediatric, Geriatric,Veterinary)), by Application (Pain management, Therapeutic interventions and Hormone replacement therapy) and Region with country level break-up.

On the basis of geography, the market of Compounding Pharmacy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Companies are hiring and training pharmacist to create medication involving a mixture of ingredients and suitable to be prescribed to the individual patient. and New regulations are being introduced in the compounding pharmacies industry globally to deal with the problem of contaminated drugs and wrong formulations


Market Trend
  • Compounding pharmacy stores which are approved by state regulatory bodies are predictable to record vigorous growth in the forecast period.
  • Increase prevalence of hormonal imbalance

Market Drivers
  • Increasing number of patients visiting physicians for treatment of chronic illness resulting in rising consumption of prescribed drugs.
  • Increased number of patients who prefer oral route drug consumption leading to demand of oral compounded prescribed medications.
  • Increase in hormone replacement therapy and positive response from community.
  • Increase in healthcare and pharmaceutical expenditure by the community.

Opportunities
  • Physiological changes in adult people
  • Rising adoption of compound medicines for chronic disease
  • Increasing demand of anti ageing product

Restraints
  • Increase in drug failure during the process of drug discovery and drug formulation.
  • Adulterated drugs being sold in the market
  • Lack of efficient regulation in place

Challenges
  • Hiring specialized laboratory technicians and pharmacists
  • Non-availability of Insurance
  • High cost equipment for compounding


Key Target Audience
Distributors, Suppliers, Traders, Wholesalers, Compounding pharmacies Manufacturers and Stakeholders

Report Objectives / Segmentation Covered

By Type
  • Oral (Capsules, Tablets, suspensions, lozenges, lollipops)
  • Topical (Cream, gel, ointments, lotions)
  • Mouthwashes
  • Suppositories
  • Injectables (Injections, infusions, concentrates, reconstitution, gels)
  • Ophthalmic
  • By end users (Adult ,Pediatric, Geriatric,Veterinary)
By Application
  • Pain management
  • Therapeutic interventions
  • Hormone replacement therapy
By Therapeutic area
  • Pain Management
  • Dermatology
  • Hormone replacement
  • Specialty drugs
  • Nutritional Supplements
  • Others

By Sterility
  • Sterile
  • Non Sterile

By End user
  • Adult
  • Pediatric
  • Geriatric
  • Veterinary

By Distribution channel
  • Hospital Pharmacy
  • Consulting pharmacy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing number of patients visiting physicians for treatment of chronic illness resulting in rising consumption of prescribed drugs.
      • 3.2.2. Increased number of patients who prefer oral route drug consumption leading to demand of oral compounded prescribed medications.
      • 3.2.3. Increase in hormone replacement therapy and positive response from community.
      • 3.2.4. Increase in healthcare and pharmaceutical expenditure by the community.
    • 3.3. Market Challenges
      • 3.3.1. Hiring specialized laboratory technicians and pharmacists
      • 3.3.2. Non-availability of Insurance
      • 3.3.3. High cost equipment for compounding
    • 3.4. Market Trends
      • 3.4.1. Compounding pharmacy stores which are approved by state regulatory bodies are predictable to record vigorous growth in the forecast period.
      • 3.4.2. Increase prevalence of hormonal imbalance
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Compounding Pharmacy, by Type, Application, Therapeutic area, Sterility, End user, Distribution channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Compounding Pharmacy (Value)
      • 5.2.1. Global Compounding Pharmacy by: Type (Value)
        • 5.2.1.1. Oral (Capsules, Tablets, suspensions, lozenges, lollipops)
        • 5.2.1.2. Topical (Cream, gel, ointments, lotions)
        • 5.2.1.3. Mouthwashes
        • 5.2.1.4. Suppositories
        • 5.2.1.5. Injectables (Injections, infusions, concentrates, reconstitution, gels)
        • 5.2.1.6. Ophthalmic
        • 5.2.1.7. By end users (Adult ,Pediatric, Geriatric,Veterinary)
      • 5.2.2. Global Compounding Pharmacy by: Application (Value)
        • 5.2.2.1. Pain management
        • 5.2.2.2. Therapeutic interventions
        • 5.2.2.3. Hormone replacement therapy
      • 5.2.3. Global Compounding Pharmacy by: Therapeutic area (Value)
        • 5.2.3.1. Pain Management
        • 5.2.3.2. Dermatology
        • 5.2.3.3. Hormone replacement
        • 5.2.3.4. Specialty drugs
        • 5.2.3.5. Nutritional Supplements
        • 5.2.3.6. Others
      • 5.2.4. Global Compounding Pharmacy by: Sterility (Value)
        • 5.2.4.1. Sterile
        • 5.2.4.2. Non Sterile
      • 5.2.5. Global Compounding Pharmacy by: End user (Value)
        • 5.2.5.1. Adult
        • 5.2.5.2. Pediatric
        • 5.2.5.3. Geriatric
        • 5.2.5.4. Veterinary
      • 5.2.6. Global Compounding Pharmacy by: Distribution channel (Value)
        • 5.2.6.1. Hospital Pharmacy
        • 5.2.6.2. Consulting pharmacy
      • 5.2.7. Global Compounding Pharmacy Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Compounding Pharmacy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AmerisourceBergen (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Rx3 Pharmacy (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agbi’s Sterile Compounding Pharmacy LLC (U.K)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun Medical Inc. (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cantrell Drug Company, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Village Sterile Compounding Pharmacy (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Imprimis Pharmaceuticals, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Institutional Pharmacies Of Louisiana LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lorraine's Pharmacy (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. McGuff Sterile Compounding Pharmacy Services, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Panaceutics Inc., Pencol Compounding Pharmacy (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Compounding Pharmacy Sale, by Type, Application, Therapeutic area, Sterility, End user, Distribution channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Compounding Pharmacy (Value)
      • 7.2.1. Global Compounding Pharmacy by: Type (Value)
        • 7.2.1.1. Oral (Capsules, Tablets, suspensions, lozenges, lollipops)
        • 7.2.1.2. Topical (Cream, gel, ointments, lotions)
        • 7.2.1.3. Mouthwashes
        • 7.2.1.4. Suppositories
        • 7.2.1.5. Injectables (Injections, infusions, concentrates, reconstitution, gels)
        • 7.2.1.6. Ophthalmic
        • 7.2.1.7. By end users (Adult ,Pediatric, Geriatric,Veterinary)
      • 7.2.2. Global Compounding Pharmacy by: Application (Value)
        • 7.2.2.1. Pain management
        • 7.2.2.2. Therapeutic interventions
        • 7.2.2.3. Hormone replacement therapy
      • 7.2.3. Global Compounding Pharmacy by: Therapeutic area (Value)
        • 7.2.3.1. Pain Management
        • 7.2.3.2. Dermatology
        • 7.2.3.3. Hormone replacement
        • 7.2.3.4. Specialty drugs
        • 7.2.3.5. Nutritional Supplements
        • 7.2.3.6. Others
      • 7.2.4. Global Compounding Pharmacy by: Sterility (Value)
        • 7.2.4.1. Sterile
        • 7.2.4.2. Non Sterile
      • 7.2.5. Global Compounding Pharmacy by: End user (Value)
        • 7.2.5.1. Adult
        • 7.2.5.2. Pediatric
        • 7.2.5.3. Geriatric
        • 7.2.5.4. Veterinary
      • 7.2.6. Global Compounding Pharmacy by: Distribution channel (Value)
        • 7.2.6.1. Hospital Pharmacy
        • 7.2.6.2. Consulting pharmacy
      • 7.2.7. Global Compounding Pharmacy Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Compounding Pharmacy: by Type(USD Million)
  • Table 2. Compounding Pharmacy Oral (Capsules, Tablets, suspensions, lozenges, lollipops) , by Region USD Million (2015-2020)
  • Table 3. Compounding Pharmacy Topical (Cream, gel, ointments, lotions) , by Region USD Million (2015-2020)
  • Table 4. Compounding Pharmacy Mouthwashes , by Region USD Million (2015-2020)
  • Table 5. Compounding Pharmacy Suppositories , by Region USD Million (2015-2020)
  • Table 6. Compounding Pharmacy Injectables (Injections, infusions, concentrates, reconstitution, gels) , by Region USD Million (2015-2020)
  • Table 7. Compounding Pharmacy Ophthalmic , by Region USD Million (2015-2020)
  • Table 8. Compounding Pharmacy By end users (Adult ,Pediatric, Geriatric,Veterinary) , by Region USD Million (2015-2020)
  • Table 9. Compounding Pharmacy: by Application(USD Million)
  • Table 10. Compounding Pharmacy Pain management , by Region USD Million (2015-2020)
  • Table 11. Compounding Pharmacy Therapeutic interventions , by Region USD Million (2015-2020)
  • Table 12. Compounding Pharmacy Hormone replacement therapy , by Region USD Million (2015-2020)
  • Table 13. Compounding Pharmacy: by Therapeutic area(USD Million)
  • Table 14. Compounding Pharmacy Pain Management , by Region USD Million (2015-2020)
  • Table 15. Compounding Pharmacy Dermatology , by Region USD Million (2015-2020)
  • Table 16. Compounding Pharmacy Hormone replacement , by Region USD Million (2015-2020)
  • Table 17. Compounding Pharmacy Specialty drugs , by Region USD Million (2015-2020)
  • Table 18. Compounding Pharmacy Nutritional Supplements , by Region USD Million (2015-2020)
  • Table 19. Compounding Pharmacy Others , by Region USD Million (2015-2020)
  • Table 20. Compounding Pharmacy: by Sterility(USD Million)
  • Table 21. Compounding Pharmacy Sterile , by Region USD Million (2015-2020)
  • Table 22. Compounding Pharmacy Non Sterile , by Region USD Million (2015-2020)
  • Table 23. Compounding Pharmacy: by End user(USD Million)
  • Table 24. Compounding Pharmacy Adult , by Region USD Million (2015-2020)
  • Table 25. Compounding Pharmacy Pediatric , by Region USD Million (2015-2020)
  • Table 26. Compounding Pharmacy Geriatric , by Region USD Million (2015-2020)
  • Table 27. Compounding Pharmacy Veterinary , by Region USD Million (2015-2020)
  • Table 28. Compounding Pharmacy: by Distribution channel(USD Million)
  • Table 29. Compounding Pharmacy Hospital Pharmacy , by Region USD Million (2015-2020)
  • Table 30. Compounding Pharmacy Consulting pharmacy , by Region USD Million (2015-2020)
  • Table 31. South America Compounding Pharmacy, by Country USD Million (2015-2020)
  • Table 32. South America Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 33. South America Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 34. South America Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 35. South America Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 36. South America Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 37. South America Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 38. Brazil Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 39. Brazil Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 40. Brazil Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 41. Brazil Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 42. Brazil Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 43. Brazil Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 44. Argentina Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 45. Argentina Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 46. Argentina Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 47. Argentina Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 48. Argentina Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 49. Argentina Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 50. Rest of South America Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 51. Rest of South America Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 52. Rest of South America Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 53. Rest of South America Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 54. Rest of South America Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 55. Rest of South America Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 56. Asia Pacific Compounding Pharmacy, by Country USD Million (2015-2020)
  • Table 57. Asia Pacific Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 58. Asia Pacific Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 59. Asia Pacific Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 60. Asia Pacific Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 61. Asia Pacific Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 62. Asia Pacific Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 63. China Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 64. China Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 65. China Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 66. China Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 67. China Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 68. China Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 69. Japan Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 70. Japan Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 71. Japan Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 72. Japan Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 73. Japan Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 74. Japan Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 75. India Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 76. India Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 77. India Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 78. India Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 79. India Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 80. India Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 81. South Korea Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 82. South Korea Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 83. South Korea Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 84. South Korea Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 85. South Korea Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 86. South Korea Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 87. Taiwan Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 88. Taiwan Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 89. Taiwan Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 90. Taiwan Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 91. Taiwan Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 92. Taiwan Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 93. Australia Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 94. Australia Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 95. Australia Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 96. Australia Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 97. Australia Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 98. Australia Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 99. Rest of Asia-Pacific Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 100. Rest of Asia-Pacific Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 101. Rest of Asia-Pacific Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 102. Rest of Asia-Pacific Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 103. Rest of Asia-Pacific Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 104. Rest of Asia-Pacific Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 105. Europe Compounding Pharmacy, by Country USD Million (2015-2020)
  • Table 106. Europe Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 107. Europe Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 108. Europe Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 109. Europe Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 110. Europe Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 111. Europe Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 112. Germany Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 113. Germany Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 114. Germany Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 115. Germany Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 116. Germany Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 117. Germany Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 118. France Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 119. France Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 120. France Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 121. France Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 122. France Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 123. France Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 124. Italy Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 125. Italy Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 126. Italy Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 127. Italy Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 128. Italy Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 129. Italy Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 130. United Kingdom Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 131. United Kingdom Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 132. United Kingdom Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 133. United Kingdom Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 134. United Kingdom Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 135. United Kingdom Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 136. Netherlands Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 137. Netherlands Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 138. Netherlands Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 139. Netherlands Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 140. Netherlands Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 141. Netherlands Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 142. Rest of Europe Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 143. Rest of Europe Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 144. Rest of Europe Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 145. Rest of Europe Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 146. Rest of Europe Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 147. Rest of Europe Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 148. MEA Compounding Pharmacy, by Country USD Million (2015-2020)
  • Table 149. MEA Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 150. MEA Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 151. MEA Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 152. MEA Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 153. MEA Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 154. MEA Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 155. Middle East Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 156. Middle East Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 157. Middle East Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 158. Middle East Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 159. Middle East Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 160. Middle East Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 161. Africa Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 162. Africa Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 163. Africa Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 164. Africa Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 165. Africa Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 166. Africa Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 167. North America Compounding Pharmacy, by Country USD Million (2015-2020)
  • Table 168. North America Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 169. North America Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 170. North America Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 171. North America Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 172. North America Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 173. North America Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 174. United States Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 175. United States Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 176. United States Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 177. United States Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 178. United States Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 179. United States Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 180. Canada Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 181. Canada Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 182. Canada Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 183. Canada Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 184. Canada Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 185. Canada Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 186. Mexico Compounding Pharmacy, by Type USD Million (2015-2020)
  • Table 187. Mexico Compounding Pharmacy, by Application USD Million (2015-2020)
  • Table 188. Mexico Compounding Pharmacy, by Therapeutic area USD Million (2015-2020)
  • Table 189. Mexico Compounding Pharmacy, by Sterility USD Million (2015-2020)
  • Table 190. Mexico Compounding Pharmacy, by End user USD Million (2015-2020)
  • Table 191. Mexico Compounding Pharmacy, by Distribution channel USD Million (2015-2020)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Compounding Pharmacy: by Type(USD Million)
  • Table 205. Compounding Pharmacy Oral (Capsules, Tablets, suspensions, lozenges, lollipops) , by Region USD Million (2021-2026)
  • Table 206. Compounding Pharmacy Topical (Cream, gel, ointments, lotions) , by Region USD Million (2021-2026)
  • Table 207. Compounding Pharmacy Mouthwashes , by Region USD Million (2021-2026)
  • Table 208. Compounding Pharmacy Suppositories , by Region USD Million (2021-2026)
  • Table 209. Compounding Pharmacy Injectables (Injections, infusions, concentrates, reconstitution, gels) , by Region USD Million (2021-2026)
  • Table 210. Compounding Pharmacy Ophthalmic , by Region USD Million (2021-2026)
  • Table 211. Compounding Pharmacy By end users (Adult ,Pediatric, Geriatric,Veterinary) , by Region USD Million (2021-2026)
  • Table 212. Compounding Pharmacy: by Application(USD Million)
  • Table 213. Compounding Pharmacy Pain management , by Region USD Million (2021-2026)
  • Table 214. Compounding Pharmacy Therapeutic interventions , by Region USD Million (2021-2026)
  • Table 215. Compounding Pharmacy Hormone replacement therapy , by Region USD Million (2021-2026)
  • Table 216. Compounding Pharmacy: by Therapeutic area(USD Million)
  • Table 217. Compounding Pharmacy Pain Management , by Region USD Million (2021-2026)
  • Table 218. Compounding Pharmacy Dermatology , by Region USD Million (2021-2026)
  • Table 219. Compounding Pharmacy Hormone replacement , by Region USD Million (2021-2026)
  • Table 220. Compounding Pharmacy Specialty drugs , by Region USD Million (2021-2026)
  • Table 221. Compounding Pharmacy Nutritional Supplements , by Region USD Million (2021-2026)
  • Table 222. Compounding Pharmacy Others , by Region USD Million (2021-2026)
  • Table 223. Compounding Pharmacy: by Sterility(USD Million)
  • Table 224. Compounding Pharmacy Sterile , by Region USD Million (2021-2026)
  • Table 225. Compounding Pharmacy Non Sterile , by Region USD Million (2021-2026)
  • Table 226. Compounding Pharmacy: by End user(USD Million)
  • Table 227. Compounding Pharmacy Adult , by Region USD Million (2021-2026)
  • Table 228. Compounding Pharmacy Pediatric , by Region USD Million (2021-2026)
  • Table 229. Compounding Pharmacy Geriatric , by Region USD Million (2021-2026)
  • Table 230. Compounding Pharmacy Veterinary , by Region USD Million (2021-2026)
  • Table 231. Compounding Pharmacy: by Distribution channel(USD Million)
  • Table 232. Compounding Pharmacy Hospital Pharmacy , by Region USD Million (2021-2026)
  • Table 233. Compounding Pharmacy Consulting pharmacy , by Region USD Million (2021-2026)
  • Table 234. South America Compounding Pharmacy, by Country USD Million (2021-2026)
  • Table 235. South America Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 236. South America Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 237. South America Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 238. South America Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 239. South America Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 240. South America Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 241. Brazil Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 242. Brazil Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 243. Brazil Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 244. Brazil Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 245. Brazil Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 246. Brazil Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 247. Argentina Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 248. Argentina Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 249. Argentina Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 250. Argentina Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 251. Argentina Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 252. Argentina Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 253. Rest of South America Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 254. Rest of South America Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 255. Rest of South America Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 256. Rest of South America Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 257. Rest of South America Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 258. Rest of South America Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 259. Asia Pacific Compounding Pharmacy, by Country USD Million (2021-2026)
  • Table 260. Asia Pacific Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 261. Asia Pacific Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 262. Asia Pacific Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 263. Asia Pacific Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 264. Asia Pacific Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 265. Asia Pacific Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 266. China Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 267. China Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 268. China Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 269. China Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 270. China Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 271. China Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 272. Japan Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 273. Japan Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 274. Japan Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 275. Japan Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 276. Japan Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 277. Japan Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 278. India Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 279. India Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 280. India Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 281. India Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 282. India Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 283. India Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 284. South Korea Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 285. South Korea Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 286. South Korea Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 287. South Korea Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 288. South Korea Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 289. South Korea Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 290. Taiwan Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 291. Taiwan Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 292. Taiwan Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 293. Taiwan Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 294. Taiwan Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 295. Taiwan Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 296. Australia Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 297. Australia Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 298. Australia Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 299. Australia Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 300. Australia Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 301. Australia Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 302. Rest of Asia-Pacific Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 303. Rest of Asia-Pacific Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 304. Rest of Asia-Pacific Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 305. Rest of Asia-Pacific Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 306. Rest of Asia-Pacific Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 307. Rest of Asia-Pacific Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 308. Europe Compounding Pharmacy, by Country USD Million (2021-2026)
  • Table 309. Europe Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 310. Europe Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 311. Europe Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 312. Europe Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 313. Europe Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 314. Europe Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 315. Germany Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 316. Germany Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 317. Germany Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 318. Germany Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 319. Germany Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 320. Germany Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 321. France Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 322. France Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 323. France Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 324. France Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 325. France Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 326. France Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 327. Italy Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 328. Italy Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 329. Italy Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 330. Italy Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 331. Italy Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 332. Italy Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 333. United Kingdom Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 334. United Kingdom Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 335. United Kingdom Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 336. United Kingdom Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 337. United Kingdom Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 338. United Kingdom Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 339. Netherlands Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 340. Netherlands Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 341. Netherlands Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 342. Netherlands Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 343. Netherlands Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 344. Netherlands Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 345. Rest of Europe Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 346. Rest of Europe Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 347. Rest of Europe Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 348. Rest of Europe Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 349. Rest of Europe Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 350. Rest of Europe Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 351. MEA Compounding Pharmacy, by Country USD Million (2021-2026)
  • Table 352. MEA Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 353. MEA Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 354. MEA Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 355. MEA Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 356. MEA Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 357. MEA Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 358. Middle East Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 359. Middle East Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 360. Middle East Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 361. Middle East Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 362. Middle East Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 363. Middle East Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 364. Africa Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 365. Africa Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 366. Africa Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 367. Africa Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 368. Africa Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 369. Africa Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 370. North America Compounding Pharmacy, by Country USD Million (2021-2026)
  • Table 371. North America Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 372. North America Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 373. North America Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 374. North America Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 375. North America Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 376. North America Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 377. United States Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 378. United States Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 379. United States Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 380. United States Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 381. United States Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 382. United States Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 383. Canada Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 384. Canada Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 385. Canada Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 386. Canada Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 387. Canada Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 388. Canada Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 389. Mexico Compounding Pharmacy, by Type USD Million (2021-2026)
  • Table 390. Mexico Compounding Pharmacy, by Application USD Million (2021-2026)
  • Table 391. Mexico Compounding Pharmacy, by Therapeutic area USD Million (2021-2026)
  • Table 392. Mexico Compounding Pharmacy, by Sterility USD Million (2021-2026)
  • Table 393. Mexico Compounding Pharmacy, by End user USD Million (2021-2026)
  • Table 394. Mexico Compounding Pharmacy, by Distribution channel USD Million (2021-2026)
  • Table 395. Research Programs/Design for This Report
  • Table 396. Key Data Information from Secondary Sources
  • Table 397. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Compounding Pharmacy: by Type USD Million (2015-2020)
  • Figure 5. Global Compounding Pharmacy: by Application USD Million (2015-2020)
  • Figure 6. Global Compounding Pharmacy: by Therapeutic area USD Million (2015-2020)
  • Figure 7. Global Compounding Pharmacy: by Sterility USD Million (2015-2020)
  • Figure 8. Global Compounding Pharmacy: by End user USD Million (2015-2020)
  • Figure 9. Global Compounding Pharmacy: by Distribution channel USD Million (2015-2020)
  • Figure 10. South America Compounding Pharmacy Share (%), by Country
  • Figure 11. Asia Pacific Compounding Pharmacy Share (%), by Country
  • Figure 12. Europe Compounding Pharmacy Share (%), by Country
  • Figure 13. MEA Compounding Pharmacy Share (%), by Country
  • Figure 14. North America Compounding Pharmacy Share (%), by Country
  • Figure 15. Global Compounding Pharmacy share by Players 2020 (%)
  • Figure 16. Global Compounding Pharmacy share by Players (Top 3) 2020(%)
  • Figure 17. Global Compounding Pharmacy share by Players (Top 5) 2020(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. AmerisourceBergen (United States) Revenue, Net Income and Gross profit
  • Figure 20. AmerisourceBergen (United States) Revenue: by Geography 2020
  • Figure 21. Rx3 Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 22. Rx3 Pharmacy (United States) Revenue: by Geography 2020
  • Figure 23. Agbi’s Sterile Compounding Pharmacy LLC (U.K) Revenue, Net Income and Gross profit
  • Figure 24. Agbi’s Sterile Compounding Pharmacy LLC (U.K) Revenue: by Geography 2020
  • Figure 25. B. Braun Medical Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 26. B. Braun Medical Inc. (Germany) Revenue: by Geography 2020
  • Figure 27. Cantrell Drug Company, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cantrell Drug Company, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 30. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India) Revenue: by Geography 2020
  • Figure 31. Village Sterile Compounding Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 32. Village Sterile Compounding Pharmacy (United States) Revenue: by Geography 2020
  • Figure 33. Imprimis Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Imprimis Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Institutional Pharmacies Of Louisiana LLC (United States) Revenue, Net Income and Gross profit
  • Figure 36. Institutional Pharmacies Of Louisiana LLC (United States) Revenue: by Geography 2020
  • Figure 37. Lorraine's Pharmacy (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Lorraine's Pharmacy (Canada) Revenue: by Geography 2020
  • Figure 39. McGuff Sterile Compounding Pharmacy Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. McGuff Sterile Compounding Pharmacy Services, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Panaceutics Inc., Pencol Compounding Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 42. Panaceutics Inc., Pencol Compounding Pharmacy (United States) Revenue: by Geography 2020
  • Figure 43. Global Compounding Pharmacy: by Type USD Million (2021-2026)
  • Figure 44. Global Compounding Pharmacy: by Application USD Million (2021-2026)
  • Figure 45. Global Compounding Pharmacy: by Therapeutic area USD Million (2021-2026)
  • Figure 46. Global Compounding Pharmacy: by Sterility USD Million (2021-2026)
  • Figure 47. Global Compounding Pharmacy: by End user USD Million (2021-2026)
  • Figure 48. Global Compounding Pharmacy: by Distribution channel USD Million (2021-2026)
  • Figure 49. South America Compounding Pharmacy Share (%), by Country
  • Figure 50. Asia Pacific Compounding Pharmacy Share (%), by Country
  • Figure 51. Europe Compounding Pharmacy Share (%), by Country
  • Figure 52. MEA Compounding Pharmacy Share (%), by Country
  • Figure 53. North America Compounding Pharmacy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AmerisourceBergen (United States)
  • Rx3 Pharmacy (United States)
  • Agbi’s Sterile Compounding Pharmacy LLC (U.K)
  • B. Braun Medical Inc. (Germany)
  • Cantrell Drug Company, Inc. (United States)
  • Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
  • Village Sterile Compounding Pharmacy (United States)
  • Imprimis Pharmaceuticals, Inc. (United States)
  • Institutional Pharmacies Of Louisiana LLC (United States)
  • Lorraine's Pharmacy (Canada)
  • McGuff Sterile Compounding Pharmacy Services, Inc. (United States)
  • Panaceutics Inc., Pencol Compounding Pharmacy (United States)
Additional players considered in the study are as follows:
Fagron (Netherlands) , ITC Compounding Pharmacy (United States)
Select User Access Type

Key Highlights of Report


Nov 2021 241 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Compounding Pharmacy Market Quantitative research analysis
Global Compounding Pharmacy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Compounding Pharmacy study can be customized to meet your requirements. The market size breakdown by type [Oral (Capsules, Tablets, suspensions, lozenges, lollipops), Topical (Cream, gel, ointments, lotions), Mouthwashes, Suppositories, Injectables (Injections, infusions, concentrates, reconstitution, gels), Ophthalmic and By end users (Adult ,Pediatric, Geriatric,Veterinary)], by end use application [Pain management, Therapeutic interventions and Hormone replacement therapy].
The Compounding Pharmacy Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Compounding Pharmacy market is expected to see growth rate of 7.6%.

Know More About Global Compounding Pharmacy Market Report?

Have a Query? Click Here

Other Related Reports

Antiemetic Drugs Comprehensive Study by Type (Dopamine Antagonist, 5-HT-3 Receptor Antagonist, NK1 Receptor Antagonist, Cannabinoid Receptor Antagonist), Application (Chemotherapy, Gastroenteritis, S...
$ 3450
Antipsychotic Drugs Comprehensive Study by Type (First Antipsychotic Drugs (Typical Antipsychotics), Second Antipsychotic Drugs (Newer Drugs), Third Antipsychotic Drugs), Application (Schizophrenia, ...
$ 3650
Narcolepsy Drug Comprehensive Study by Type (Antioxidants Type, Stimulants Type, Other), Application (Daytime Extreme Sleepiness, Cataplexia, Others), Narcolepsy Type (Type 1 Narcolepsy, Type 2 Narco...
$ 3750
Rosuvastatin Calcium Comprehensive Study by Type (Purity 98.0%, Purity 99.0%, Other), Application (Capsule, Gel, Tablet), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmaci...
$ 3500
Krill Oil Comprehensive Study by Type (Liquid, Tablet), Application (Dietary Supplements, Pet and Animal Food, Food and Beverages, Pharmaceuticals), Distribution Channel (Offline, Online), Packaging ...
$ 3500
Codeine Phosphate Comprehensive Study by Type (Extracted from Opium, Synthesized by Morphine), Application (Narcotic Analgesic, Antitussive, Others), End-users (Hospitals, Clinics, Others), Distribut...
$ 3450